These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18102886)

  • 21. [ON EXTERNAL THERAPY OF DISEASES OF THE POLYARTHRITIC TYPE].
    MUELLER G
    Dtsch Med J; 1964 Mar; 15():182-3. PubMed ID: 14189784
    [No Abstract]   [Full Text] [Related]  

  • 22. Biologic assay of mercury ointments.
    LAUG EP; VOS EA; KUNZE FM
    J Am Pharm Assoc Am Pharm Assoc; 1947 Jan; 36(1):14. PubMed ID: 20285820
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceutical preparations for the profession.
    HOFFMAN HL
    J Am Podiatry Assoc; 1962 Jan; 52():51-3. PubMed ID: 13908103
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays.
    Meany D; Schowinsky J; Clarke W
    Clin Biochem; 2008 Dec; 41(18):1486-8. PubMed ID: 18950612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CONTRIBUTION TO THE ANALYSIS OF URGUENTUM BRONCHO-RESORBENS PM].
    SCHALLER P
    Pharm Acta Helv; 1963; 38():430-6. PubMed ID: 14052336
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimization and validation of liquid chromatography and headspace-gas chromatography based methods for the quantitative determination of capsaicinoids, salicylic acid, glycol monosalicylate, methyl salicylate, ethyl salicylate, camphor and l-menthol in a topical formulation.
    Pauwels J; D'Autry W; Van den Bossche L; Dewever C; Forier M; Vandenwaeyenberg S; Wolfs K; Hoogmartens J; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2012 Feb; 60():51-8. PubMed ID: 22094014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [DISPENSARY TREATMENT OF PATIENTS WITH FOOT EPIDERMOPHYTOSIS].
    NERADOV LA; KARAGEZIAN MA
    Vestn Dermatol Venerol; 1963 Dec; 37():49-52. PubMed ID: 14149470
    [No Abstract]   [Full Text] [Related]  

  • 28. A water-miscible tar-sulphur-salicylic ointment.
    MYERS JA
    Australas J Pharm; 1949 May; 30(353):575. PubMed ID: 18145825
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmaceutical factors influencing the release and absorption of salicylic acid from ointments].
    Dobrotvorskiĭ AE
    Farmatsiia; 1973; 22(5):22-5. PubMed ID: 4754797
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON THE ASSAY OF SOME MERCURIAL OINTMENTS].
    DUCHLEITER L; ILVER K; MADSEN A
    Dan Tidsskr Farm; 1964 Jul; 38():127-39. PubMed ID: 14181373
    [No Abstract]   [Full Text] [Related]  

  • 31. [Toxic inner ear damage in topical treatment of psoriasis with salicylates].
    Maune S; Frese KA; Mrowietz U; Reker U
    Laryngorhinootologie; 1997 Jun; 76(6):368-70. PubMed ID: 9333282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PERCUTANEOUS ABSORPTION OF HEPARIN IN RABBIT'S EAR.
    KONTTINEN Y
    Ann Med Exp Biol Fenn; 1965; 43():43-8. PubMed ID: 14312355
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a plasma salicylate assay service in a medical unit in Hong Kong: a follow-up study.
    Chan TY; Chan AY
    Vet Hum Toxicol; 1996 Aug; 38(4):278-9. PubMed ID: 8829346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A TOPICAL ADJUVANT FOR THE TREATMENT OF PSORIASIS.
    LUBOWE II
    Clin Med (Northfield); 1964 Apr; 71():649-54. PubMed ID: 15446142
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantitative analysis of active components in ointments by x-ray diffractometry. 3. Analysis of salicylic acid, ethyl aminobenzoate and sulfisomidin in ointments].
    Kuroda K; Hashizume G
    Yakugaku Zasshi; 1967 Feb; 87(2):159-63. PubMed ID: 6069355
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE FIXATION OF THE FORMULA FOR WHITFIELD'S OINTMENT FOR FUNGUS INFECTIONS OF THE SKIN].
    SCHMITZ R
    Hautarzt; 1964 Jan; 15():44. PubMed ID: 14134559
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of triethanolamine salicylate release from the dermatological bases and the commercial products.
    Babar A; Chickhale PJ; Plakogiannis FM
    Pharm Acta Helv; 1991; 66(12):322-8. PubMed ID: 1784579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [THE PERCUTANEOUS ABSORPTION OF SALICYLIC ACID FROM MODERN OINTMENT BASES].
    GSTIRNER F; ELSNER R
    Arzneimittelforschung; 1964 Apr; 14():281-6. PubMed ID: 14238571
    [No Abstract]   [Full Text] [Related]  

  • 39. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Chyka PA; Erdman AR; Christianson G; Wax PM; Booze LL; Manoguerra AS; Caravati EM; Nelson LS; Olson KR; Cobaugh DJ; Scharman EJ; Woolf AD; Troutman WG; ;
    Clin Toxicol (Phila); 2007; 45(2):95-131. PubMed ID: 17364628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EXPERIENCE WITH MOBILAT OINTMENT IN SPORT ACCIDENTS].
    DIETZ H; SCHRAMM S
    Med Monatsschr; 1964 Aug; 18():372-5. PubMed ID: 14247949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.